Accomplished molecular microbiologist and protein engineer takes charge of CSIR-IMTECH after serving in key scientific and regulatory leadership roles at FSSAI
The acquisition reflects Johnson & Johnson’s push to strengthen its position in antibody engineering and next-generation oncology modalities
At 34 weeks, Ultomiris achieved a 43.4% placebo-adjusted reduction in 24-hour urine protein creatinine ratio (UPCR) versus placebo, meeting the study’s key interim endpoint
The campaign places renewed focus on a disease that remains incurable despite major scientific advances
The agreement underscores Roche’s commitment to advancing innovative therapies for blood cancers and other serious diseases
Collaboration brings Staart Prime, ChilRun and NikoMom products to Yoginii’s platform, strengthening its family-focused wellness ecosystem and supporting women through motherhood and family care
We have the chance to build an IP estate that goes hand in hand with our generic pharmaceutical strength and build proprietary biological platforms
The approval marks a major milestone in the global fight against antimicrobial resistance
Ariane brings a strong track record within Ardena, including her leadership of the company’s drug product division since 2022
MeziKd delivered stronger response rates across multiple patient groups, including those receiving second- and third-line treatment and patients with higher-risk disease
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
